Table 2.
Candidate lncRNAs biomarkers associated with clinically molecular subtype and prognosis of DLBCL
| Ensembl id | Gene symbol | Chromosomal position | p-value | FDR | signal-to-noise ratio |
|---|---|---|---|---|---|
| ENSG00000226688.5 | ENTPD1-AS1 | Chr 10: 95,753,206-96,090,238 (−) | 5.34E-10 | 1.78E-07 | 0.453 |
| ENSG00000229558.2 | SACS-AS1 | Chr 13: 23,418,971-23,428,869 (+) | 2.2E-07 | 3.94E-05 | 0.404 |
| ENSG00000224660.1 | SH3BP5-AS1 | Chr 3: 15,254,184-15,264,493 (+) | 4.93E-12 | 3.83E-09 | 0.502 |
| ENSG00000231090.1 | RP11-101C11.1 | Chr 1: 55,217,861-55,234,177 (+) | 3.88E-09 | 1.13E-06 | 0.421 |
| ENSG00000224730.1 | AC009892.10 | Chr 19: 54,635,722-54,638,892 (−) | 1.03E-07 | 2.36E-05 | 0.38 |
| ENSG00000255443.1 | RP1-68D18.4 | Chr 11: 35,210,343-35,214,985 (−) | 3.48E-07 | 5.8E-05 | 0.361 |
| ENSG00000236901.4 | MIR600HG | Chr 9: 123,109,494-123,115,477 (−) | 9.02E-07 | 1.4E-04 | 0.359 |
| ENSG00000279130.1 | RP11-278 J6.4 | Chr 5: 143,406,959-143,407,420 (+) | 2.57E-06 | 3.737E-04 | 0.341 |
| ENSG00000260303.1 | RP11-203B7.2 | Chr 4: 146,052,604-146,056,762 (−) | 1.33E-07 | 2.57E-05 | 0.395 |
| ENSG00000231163.4 | CSMD2-AS1 | Chr 1: 33,868,953-33,885,458 (+) | 2.76E-10 | 1.29E-07 | 0.493 |
| ENSG00000245864.2 | CTC-467 M3.1 | Chr 5: 88,676,218-88,722,831 (+) | 1.12E-07 | 2.36E-05 | 0.379 |
| ENSG00000223479.3 | RP4-788P17.1 | Chr 1: 73,635,216-73,715,214 (+) | 2.91E-12 | 3.39E-09 | 0.514 |
| ENSG00000259976.1 | RP11-553 L6.5 | Chr 3: 114,314,501-114,316,179 (−) | 6.09E-08 | 1.58E-05 | 0.386 |
| ENSG00000245694.7 | CRNDE | Chr 16: 54,918,863-54,929,189 (−) | 3.49E-06 | 4.71E-04 | 0.328 |
| ENSG00000259354.4 | RP11-519G16.3 | Chr 15: 45,448,427-45,513,767 (+) | 3.7E-10 | 1.44E-07 | 0.494 |
| ENSG00000254418.1 | RP11-21 L19.1 | Chr 11: 14,262,846-14,273,691 (−) | 2.96E-11 | 1.73E-08 | 0.507 |
| ENSG00000240666.2 | MME-AS1 | Chr 3: 155,158,370-155,183,285 (−) | 4.33E-15 | 1.01E-11 | 0.666 |